Improved diagnostic solutions contribute to the development of more precise and personalised medicine and improve the quality of life for patients worldwide. Founded in 2008, Innobiochips provides novel, breakthrough technologies and solutions to improve the accuracy, quality and sustainability of in vitro diagnostic approaches.
Vianney Souplet, CEO of Innobiochips:
“As part of the Eurasanté healthcare cluster since our foundation, we have a keen interest in contributing to events that promote connections and innovation in healthcare.”
Under the motto “Understanding Life“, the company focuses on diagnostic technologies for better Transplantations and Transfusions, as well as Infectious Diseases and Inflammation diagnostics. These areas of focus are reflected in the company’s three core values: Innovation, Performance and Responsibility.
With years of ISO 13485 certification, various CE-marked solutions developed, and more than 1 million biological tests produced per year, the company continues to demonstrate excellence in the field.
We are very grateful to see them support MedFIT and BioFIT!
